IN8bio, Inc.
INAB
$1.10
-$0.08-6.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.96M | 21.94M | 27.09M | 10.69M | 13.23M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 176.00K | 326.00K | 529.00K | 733.00K | 145.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 364.00K | 395.00K | 259.00K | 346.00K | 370.00K |
| Total Current Assets | 18.50M | 22.66M | 27.88M | 11.77M | 13.74M |
|
|
|||||
| Total Current Assets | 18.50M | 22.66M | 27.88M | 11.77M | 13.74M |
| Net Property, Plant & Equipment | 2.97M | 3.25M | 4.04M | 4.56M | 5.08M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 278.00K | 349.00K | 366.00K | 442.00K | 546.00K |
| Total Assets | 21.75M | 26.27M | 32.28M | 16.77M | 19.37M |
|
|
|||||
| Total Accounts Payable | 444.00K | 449.00K | 309.00K | 204.00K | 379.00K |
| Total Accrued Expenses | 761.00K | 681.00K | 1.63M | 418.00K | 635.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.05M | 1.03M | 1.22M | 1.08M | 940.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.25M | 2.16M | 3.16M | 1.70M | 1.95M |
|
|
|||||
| Total Current Liabilities | 2.25M | 2.16M | 3.16M | 1.70M | 1.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.13M | 1.33M | 1.56M | 1.88M | 2.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.38M | 3.48M | 4.72M | 3.58M | 4.13M |
|
|
|||||
| Common Stock & APIC | 169.33M | 168.97M | 168.65M | 149.34M | 147.54M |
| Retained Earnings | -150.97M | -146.19M | -141.10M | -136.15M | -132.30M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 18.36M | 22.78M | 27.56M | 13.19M | 15.24M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.36M | 22.78M | 27.56M | 13.19M | 15.24M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.36M | 22.78M | 27.56M | 13.19M | 15.24M |
|
|
|||||